3 Reasons Bristol Myers Squibb's Revenue Skyrocketed in Q1

3 Reasons Bristol Myers Squibb's Revenue Skyrocketed in Q1

Source: 
Motley Fool
snippet: 

Bristol Myers Squibb (NYSE:BMY) announced its first-quarter results before the market opened on Thursday. The big pharma company did exactly what it needed to, delivering strong growth and handily beating analysts' estimates.